基金持股分佈(依持有類股) 資料日期:2024/11/15 |
|
基金持股分佈(依產業)
資料日期:2024/10/31 |
|
基金持股分佈(依區域)
資料日期:2024/10/31 |
|
富邦基因免疫生技ETF基金-持股明細 資料月份:2024/10 |
股票名稱 | 持股(千股) | 比例 | 增減 |
股票名稱 | 持股(千股) | 比例 | 增減 |
EXELIXIS INC |
N/A |
5.87 |
1.20% |
NOVAVAX INC |
N/A |
1.45 |
-0.40% |
GILEAD SCIENCES INC |
N/A |
5.40 |
0.30% |
MODERNA INC |
N/A |
1.43 |
-0.31% |
百濟神州 |
N/A |
5.33 |
-0.68% |
BLUEPRINT MEDICINES CORP |
N/A |
1.35 |
-0.04% |
REVOLUTION MEDICINES INC |
N/A |
4.96 |
0.53% |
ONO PHARMACEUTICAL CO LTD |
N/A |
1.05 |
-0.06% |
INCYTE CORP |
N/A |
4.95 |
0.55% |
CRISPR Therapeutics AG |
N/A |
0.96 |
0.02% |
Roche Holding AG |
N/A |
4.62 |
-0.06% |
IMMUNITYBIO INC |
N/A |
0.96 |
0.33% |
BioNTech SE |
N/A |
4.50 |
-0.16% |
ABLBIO INC |
N/A |
0.92 |
0.12% |
Sanofi |
N/A |
4.29 |
-0.30% |
ARCUS BIOSCIENCES INC |
N/A |
0.85 |
0.04% |
Sarepta Therapeutics Inc |
N/A |
4.10 |
0.11% |
VIR BIOTECHNOLOGY INC |
N/A |
0.75 |
0.02% |
TAKEDA PHARMACEUTICAL CO LTD |
N/A |
4.07 |
-0.14% |
ABCELLERA BIOLOGICS INC |
N/A |
0.63 |
0.04% |
ARCELLX INC |
N/A |
3.85 |
0.17% |
ARCTURUS THERAPEUTICS HOLDINGS |
N/A |
0.50 |
-0.13% |
Regeneron Pharmaceuticals Inc |
N/A |
3.64 |
-0.49% |
OMNIAB INC |
N/A |
0.42 |
-0.02% |
GSK PLC |
N/A |
3.50 |
-0.36% |
4D MOLECULAR THERAPEUTICS INC |
N/A |
0.40 |
-0.12% |
GENMAB A/S |
N/A |
3.20 |
-0.22% |
VALNEVA SE |
N/A |
0.34 |
-0.01% |
MERCK & CO INC |
N/A |
3.18 |
-0.24% |
Intellia Therapeutics Inc |
N/A |
0.34 |
-0.14% |
IOVANCE BIOTHERAPEUTICS INC |
N/A |
2.73 |
0.42% |
uniQure NV |
N/A |
0.33 |
0.07% |
Twist Bioscience Corp |
N/A |
2.66 |
-0.11% |
Xencor Inc |
N/A |
0.31 |
0.01% |
GERON CORP |
N/A |
2.30 |
-0.20% |
GINKGO BIOWORKS HOLDINGS INC |
N/A |
0.30 |
-0.01% |
SPRINGWORKS THERAPEUTICS INC |
N/A |
2.22 |
-0.10% |
CUREVAC NV |
N/A |
0.29 |
-0.01% |
LIGAND PHARMACEUTICALS INC |
N/A |
2.13 |
0.20% |
TOOLGEN INC |
N/A |
0.27 |
-0.01% |
BEAM THERAPEUTICS INC |
N/A |
1.91 |
-0.16% |
EDITAS MEDICINE INC |
N/A |
0.27 |
-0.04% |
BIOCRYST PHARMACEUTICALS INC |
N/A |
1.83 |
0.18% |
MACROGENICS INC |
N/A |
0.22 |
0.01% |
DYNAVAX TECHNOLOGIES CORP |
N/A |
1.74 |
0.15% |
NXERA PHARMA CO LTD |
N/A |
0.14 |
-0.02% |
NURIX THERAPEUTICS INC |
N/A |
1.51 |
0.11% |
|
|
|
|
(1)股票型及平衡型基金自91年7月份起放寬為每月公布基金持股前五大個股名稱,及合計占基金淨資產價值之比例;每季(3、6、9、12月)公布基金投資個股內容及比例。
(2)國內募集投資國外之股票型基金,放寬為每季公布基金持股前五大個股名稱,及合計占基金淨資產價值之比例;每半年公布基金投資個股內容及比例。 |